• FAQs
  • Contact
  • Sign In
SciRank Logo
  • CDMO/CRO Directory
  • Biotech Startup Pack
  • Categories
  • Leave a Review
Add CDMO/CRO
SciRank Logo
  • CDMO/CRO Directory
  • Biotech Startup Pack
  • Categories
  • Leave a Review
  • FAQs
  • Contact
Add CDMO/CRO
Biotech Startup Pack
  • home
  • CDMO/CRO Directory

Enable Biotech Zug , Switzerland

CDMO Logo

Enable Biotech

https://www.enablebiotech.com
Baarerstrasse 8
Zug , 6300
Switzerland
0 reviews
Leave a Review Claim Listing

Categories
  • Cell Therapy Supplier
  • Gene Therapy Supplier
  • Exosome Supplier
  • About
  • Service Offerings
  • Reviews
  • Locations

About Enable Biotech :

Enable Biotech Ltd, founded in 2023 in Zug, Switzerland, is a contract development and manufacturing organization offering innovative custom fee-for-service activities in the development and clinical manufacturing of Cell & Gene Therapies (ATMPs) and Exosome Therapies. As part of its service offering, Enable Biotech offers clinical GMP manufacturing activities for Cell Therapies and Exosome Therapies.

Service Offerings:

  • Process Development
  • Formulation Development
  • Analytical Development & Validation
  • PBMC (T Cells. NK cells. Invariant NK Cells. iPSC. MSC. HLSC)
  • Preparation of CMC Module 3 sections

Reviews:

No Reviews
Leave a Review
Add Location
SciRank Logo

SciRank was started to help Biotech companies select the best vendors based on firsthand user-generated insight and data. At SciRank, we provide you with user reviews, ratings and aggregated data on vendor capabilities so that you can make the choices that are right for you.

  • Add CDMO/CRO
  • Leave A Review
Company
  • About Us
  • Scoring Methodology
  • FAQs
  • Contact
Policies
  • Privacy Policy
  • Terms of Service
  • Acceptable Use Policy
  • Cookie Policy
  • Refund Policy
Company
  • About Us
  • Scoring Methodology
  • FAQs
  • Contact
Policies
  • Privacy Policy
  • Terms of Service
  • Acceptable Use Policy
  • Cookie Policy
  • Refund Policy
© 2026 SciRank. All rights reserved.